MRD Monitoring in Acute Lymphoblastic Leukemia

0 Views
administrator
administrator
06/15/23

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next